Given IDH has emerged as a hallmark gene in glioblastoma diagnostics with a significant impact on tumor metabolism, it is necessary to investigate glioblastoma cohorts with a homogenous IDH mutation status [17]. The gene discussed is IDH1; the disease is neoplasm.